Maryam Elmi, MD
Surgical Oncology · San Antonio, TXNPI 1144715384
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 65.8% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2022 at $9,626 and has fallen 91.4% since, to $828 in 2025.
Across 70 payments — averaging $172.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Stryker$2K
- Molli Surgical (US) Inc$323
- AstraZeneca$207
- Bard Peripheral Vascular, Inc.$193
- Novartis$146
- plus $1K from 26 others
What the payments were for
- Travel & lodging$2,53321%
- Food & beverage$2,47720%
- Education$7,09159%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $7,966 |
| Stryker | 13 | $2,149 |
| Molli Surgical (US) Inc | 2 | $323 |
| AstraZeneca(2 entities) | 5 | $207 |
| Bard Peripheral Vascular, Inc. | 3 | $193 |
| Novartis | 2 | $146 |
| Dexcom, Inc. | 1 | $122 |
| Endomagnetics Ltd | 1 | $106 |
| Merit Medical Systems Inc | 1 | $89 |
| Bayer | 3 | $79 |
| Incyte Corporation | 3 | $66 |
| Genmab U.S., Inc. | 2 | $57 |
| TELA Bio, Inc. | 1 | $56 |
| Merck | 2 | $49 |
| Iovance Biotherapeutics, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $45 |
| EMD Serono, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $42 |
| AVEO Pharmaceuticals, Inc. | 2 | $40 |
| Eisai Inc. | 2 | $40 |
| Coherus Oncology, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Legend Biotech USA Inc. | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $19 |
| Geron Corporation | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Baxter Healthcare | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$7,000
- EIKON$1,711
- Da Vinci Surgical System$863
- SPY-PHI SYSTEM$170
- ENTRESTO$125
- DEXCOM G6 TRANSMITTER$122
- EIKON LT$121
- Enhertu$115
- Magseed$106
- Magtrace$106
How this compares
$12,101 in reported general payments places this provider in the 80th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine-PrilocaineLidocaine/Prilocaine | 61 | $709 |
| Cephalexin | 65 | $633 |
| Gabapentin | 82 | $234 |
| Ondansetron OdtOndansetron | 51 | $169 |
| Ondansetron Hcl | 24 | $58 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in San Antonio
- Alfredo Santillan GomezSan Antonio$125K
- Mio KitanoSan Antonio$32K
- Farbod MalekSan Antonio$16K
- Allan WhiteSan Antonio$5K
- Alexander ParikhSan Antonio$5K
- Federico TozziSan Antonio$4K
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
- Steven CurleyTyler$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.